GHO Capital Partners

• GHO Capital Partners Acquires Scientist.com

  November 20, 2025

  Buyer

  GHO Capital Partners LLP

  Target

  Scientist.com

  Industry

  Cloud & SaaS

  Location

  California, United States

  Type

  Buyout

  GHO Capital Partners LLP acquired Scientist.com, the AI-enabled R&D orchestration platform for life sciences, in a deal intended to accelerate global scale and technology development. Scientist.com will expand platform adoption (including across Europe) and invest in next-generation AI/automation capabilities for outsourced R&D procurement and compliance workflows.

• ELIQUENT Life Sciences Acquires Azzur Consulting

  May 7, 2025

  Buyer

  ELIQUENT Life Sciences, GHO Capital

  Target

  Azzur Consulting

  Industry

  Healthcare Services

  Location

  United States

  Type

  Addon

  ELIQUENT Life Sciences, a GHO Capital‑backed global regulatory, quality, and safety consulting firm, has acquired Azzur Consulting to strengthen its validation engineering, CQV, and quality/compliance capabilities. The Azzur team will integrate into ELIQUENT's global delivery organization to expand technical delivery across North America, Europe, Japan and other markets.

• GHO Capital and Ampersand Acquire Avid Bioservices for $1.1 Billion

  November 7, 2024

  Buyer

  GHO Capital Partners LLP, Ampersand Capital Partners

  Target

  Avid Bioservices

  Seller

  Avid Bioservices stockholders

  Industry

  Biotechnology

  Location

  California, United States

  Type

  Buyout

  GHO Capital Partners and Ampersand Capital Partners have completed the acquisition of Avid Bioservices, a dedicated biologics CDMO, in an all-cash transaction valued at approximately $1.1 billion. The transaction takes Avid private (shareholders received $12.50 per share) and positions the company for capability expansion, geographic reach and accelerated growth under the new PE ownership.

• Ardena Acquires Catalent's Somerset, New Jersey Drug Product Facility

  October 14, 2024

  Buyer

  Ardena, GHO Capital Partners LLP

  Target

  Catalent (Somerset, New Jersey manufacturing facility)

  Seller

  Catalent

  Industry

  Pharmaceuticals

  Location

  New Jersey, United States

  Type

  Addon

  Ardena, a GHO Capital-backed CDMO, has signed a definitive agreement to acquire Catalent's FDA-approved drug product manufacturing facility in Somerset, New Jersey. The acquisition — expected to close in early 2025 subject to approvals — expands Ardena's US footprint and downstream capabilities in oral solid dosage manufacturing and bioanalytical services.

• ELIQUENT Life Sciences Acquires RApport Global Strategic Services

  January 22, 2024

  Buyer

  ELIQUENT Life Sciences, GHO Capital Partners LLP

  Target

  RApport Global Strategic Services

  Industry

  Healthcare Services

  Location

  Surrey, United Kingdom

  Type

  Addon

  ELIQUENT Life Sciences, a GHO Capital-backed global regulatory consultancy, has acquired UK-based RApport Global Strategic Services to expand its European regulatory capabilities. The deal adds RApport's European regulatory expertise to ELIQUENT's existing US and Asia Pacific capabilities, enabling enhanced end-to-end regulatory solutions for life sciences clients.

• Sanner Group Acquires Springboard Pro

  January 3, 2024

  Buyer

  Sanner Group, GHO Capital Partners LLP

  Target

  Springboard Pro

  Industry

  Medical Devices

  Location

  Cambridgeshire, United Kingdom

  Type

  Addon

  Sanner Group, a GHO Capital-backed medical device CDMO, has acquired Springboard Pro, a Cambridge-based specialist in design and development of regulated medical devices. The acquisition strengthens Sanner's in-house medical technology and diagnostics development capabilities and establishes a new Design Center of Excellence in the UK.

• GHO Capital and Partners Group Invest in Sterling Pharma Solutions

  May 25, 2023

  Buyer

  GHO Capital Partners LLP, Partners Group, AlpInvest Partners (funds managed by AlpInvest), Pantheon

  Target

  Sterling Pharma Solutions

  Industry

  Pharmaceuticals

  Location

  United Kingdom

  Type

  Growth capital

  GHO Capital (majority owner) and Partners Group have completed an investment into GHO portfolio company Sterling Pharma Solutions, with Partners Group acquiring a significant minority stake. The transaction is supported by a consortium led by funds managed by AlpInvest Partners and Pantheon and will fund Sterling's expansion of production capacity, capability build-out and further strategic acquisitions across the UK, Europe and the US.

• Sterling Pharma Solutions Acquires Novartis Ringaskiddy API Manufacturing Facility

  January 11, 2023

  Buyer

  Sterling Pharma Solutions, GHO Capital Partners LLP

  Target

  Novartis Ringaskiddy facility (Novartis Ringaskiddy Limited)

  Seller

  Novartis

  Industry

  Pharmaceuticals

  Location

  County Cork, Ireland

  Type

  Addon

  Sterling Pharma Solutions, a GHO Capital portfolio company, has completed the acquisition of the Novartis API manufacturing facility in Ringaskiddy, County Cork, Ireland. The 111-acre site (with ~350 transferred employees and extensive commercial-scale API production capacity) expands Sterling's European manufacturing footprint and includes an ongoing supply agreement with Novartis.

• GHO Capital and The Vistria Group Acquire Alcami Corporation

  January 3, 2023

  Buyer

  GHO Capital Partners LLP, The Vistria Group

  Target

  Alcami Corporation

  Seller

  Madison Dearborn Partners, Ampersand Capital Partners

  Industry

  Healthcare Services

  Location

  North Carolina, United States

  Type

  Buyout

  GHO Capital Partners and The Vistria Group have acquired a 50/50 controlling interest in Alcami Corporation from funds affiliated with Madison Dearborn Partners and Ampersand Capital Partners. Alcami is a US-based contract development and manufacturing organization (CDMO) with capabilities in sterile fill-finish, formulation and analytical lab services, and cGMP biostorage; Ampersand and Alcami management reinvested significant equity as part of the transaction.

• Velocity Clinical Research Acquires Meridian Clinical Research

  December 15, 2022

  Buyer

  Velocity Clinical Research, GHO Capital Partners LLP

  Target

  Meridian Clinical Research

  Industry

  Healthcare Services

  Location

  Nebraska, United States

  Type

  Addon

  Velocity Clinical Research, a GHO-backed integrated research site organization, has acquired Meridian Clinical Research for an undisclosed amount. The deal creates the largest dedicated clinical research site organization globally (about 80 sites), expands Velocity's U.S. footprint to 25 states and adds Meridian's network of 35+ sites and experienced investigators and staff.

• GHO Capital Partners Acquires Majority Stake in Sapio Sciences

  December 1, 2022

  Buyer

  GHO Capital Partners

  Target

  Sapio Sciences

  Industry

  Cloud & SaaS

  Location

  Maryland, United States

  Type

  Buyout

  London-based healthcare investor GHO Capital Partners has acquired a majority stake in Sapio Sciences, a US-based lab informatics platform providing LIMS, ELN and scientific data management solutions. GHO will support Sapio's international expansion (especially into Europe), operational improvements and growth through M&A to scale the company's SaaS offering for biopharma, CROs and diagnostic labs.

• Biocare Medical Acquires Empire Genomics

  November 23, 2022

  Buyer

  Biocare Medical, GHO Capital Partners LLP

  Target

  Empire Genomics

  Industry

  Biotechnology

  Location

  New York, United States

  Type

  Addon

  Biocare Medical, a GHO Capital-backed provider of automated IHC and FISH instrumentation and reagents, has acquired Empire Genomics, a designer and manufacturer of FISH/CISH probes and molecular biomarkers. The deal expands Biocare's molecular portfolio (bringing over one million biomarkers) and adds rapid biomarker development capabilities to accelerate cancer research and diagnostics.

Related Acquisition Pages